Floatz logo

ksx01-tcrt

TCR-T Cells

TCRx Therapeutics Co.LtdCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the TCR-T Cells cohort.

Asset / SponsorPhaseRating
ksh01
TCRx Therapeutics Co.Ltd
Early Phase 1C

Same molecule, other indications

ksx01-tcrt is also rated in:

Refractory Solid TumorsDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →